Marmycins are known anticancer drugs. However, the synthesis of Marmycin analogues is complicated, involving multiple steps. It would be highly advantageous to develop new and improved methods of synthesizing Marmycin analogues to investigate their medicinal properties. In addtion, it would be advantageous to use light as a reagent to synthesize Marmycin analogues/core.
Provided is a method for synthesizing a compound, the method comprising reacting a 1,3-dicarbonyl compound with an alkene or alkenyl amine in a solvent in the presence of light to obtain a photoadddition product. In certain embodiments, the photoaddition product is the only product of the reaction between the 1,3-dicarbonyl compound and the alkene. Many commercially available solvents may be used.
In certain embodiments, the 1,3-dicarbonyl compound has a formula I:
wherein R1 and R2 are each, independently, a carbon-based chain, heterocyclic moiety, cyclic moiety, or heteroatom. In particular embodiments, R1 is an alkyl group, and R2 is an alkyl, aryl, aryloxy, or haloaryl. In particular embodiments, the R1 is methyl. In particular embodiments, R2 is selected from the group consisting of methyl, phenyl, flourophenyl, naphthyl, and methoxy phenyl.
In certain embodiments, the 1,3-dicarbonyl compound has formula (101):
wherein dashed lines indicate one or more optional bonds, and each of R3, R4, and R5 is independently selected from alkyl, cycloalkyl, aryl, heterocyclic, alkoxy, aryloxy, amines, thiols, phosphonates, carboxylates, sulfonates, nitriles, thioethers, thioamides, thioketones, azides, sulfides, disulfides, ethers, epoxides, nitrates, nitrites, nitro compounds, nitroso compounds, imides, cyanates, isocyanates, thiocyanates, isothiocyanates, sulfoxides, sulfones, sulfites, phosphites, thial, phosphines, and aldehydes.
In certain embodiments, the 1,3-dicarbonyl compound is diketone 1a:
In certain embodiments, the 1,3-dicarbonyl compound is diketone 1b:
In certain embodiments, the 1,3-dicarbonyl compound is diketone 1c:
In certain embodiments, the 1,3-dicarbonyl compound is diketone 1e:
In certain embodiments, the 1,3-dicarbonyl compound is diketone 1d:
In certain embodiments, the alkene comprises a carbon-carbon double bond and an amine. In certain embodiments, the alkene comprises an aryl alkene. In certain embodiments, the alkenyl amine comprises amino-styrene.
In certain embodiments, the alkene comprises an alkenyl amine having formula II:
where the dashed lines represent a linker that can be an alkyl chain, a carbocycle, a heterocyclic moiety, or any combination of C—C or C-heteroatom bonds that separates the alkenyl group from the amine group; and R3 is H or a carbon-based chain, heterocyclic moiety, cyclic moiety, or heteroatom.
In certain embodiments, the alkene comprises an aryl amine. In certain embodiments, the alkenyl amine comprises an amino-styrene.
In certain embodiments, the alkene comprises formula (200):
where dashed lines indicate optional bonds; RA is selected from the group consisting of H, alkyl, alkene, alkyne, aryl, heterocyclic, alkenyl halide, unsaturated enones, unsaturated ketones, unsaturated amides, unsaturated alcohols, unsaturated amines, unsaturated thiols, phosphonates, carboxylates, sulfonates, nitriles, thioethers, thioamides, thioketones, azides, sulfides, disulfides, ethers, epoxides, nitrates, nitrites, nitro compounds, nitroso compounds, imides, cyanates, isocyantes, thiocyanates, isothiocyanates, sulfoxides, sulfones, sulfites, phoshites, thial, phosphines, or aldheydes; RB is alkene, arene, or heteroarene. In particular embodiments, RA has formula (201):
where each of A, B, and C is independently selected from the group consisting of H, alkyl, alkene, alkynes, aryl, heterocyclic, alkenyl halides, unsaturated enones, unsaturated ketones, unsaturated amides, unsaturated alcohols, unsaturated amines, unsaturated thiols, phosphonates, carboxylates, sulfonates, nitriles, thioethers, thioamides, thioketones, azides, sulfides, disulfides, ethers, epoxides, nitrates, nitrites, nitro compounds, nitroso compounds, imides, cyanates, isocyanates, thiocyanates, isothiocyanates, sulfoxides, sulfones, sulfites, phosphites, thial, phosphines, and aldehydes.
In certain embodiments, the alkene comprises amino-styrene 2a:
In certain embodiments, the alkene comprises amino-styrene 2b:
In certain embodiments, the photoaddition product is a bicyclic compound. In certain embodiments, the photoaddition product is a dihydropyran. In certain embodiments, the photoaddition product is a bicylic comound that features a Marmycin core. In certain embodiments, the photoaddition product is a Marmycin analogue.
In certain embodiments, the photoaddition product has formula III:
where the dashed lines represent a linker that can be an alkyl chain, a carbocycle or a heterocyclic moiety, or a combination of C—C or C-heteroatom bonds; and each of IV, R2, and R3 is, independently, H or a carbon-based chain, cyclic moiety, heterocylic moiety, or heteroatom. In particular embodiments, R1 is an alkyl group, and R2 is an alkyl, aryl, aryloxy, haloaryl, heterocycle, heteroatom, or a combination of carbocycle, chain, heterocycle, or heteroatom. In particular embodiments, R1 is methyl. In particular embodiments, R2 is selected from the group consisting of methyl, phenyl, and fluorophenyl, naphthyl, and methoxy phenyl, and R3 is H.
In certain embodiments, the photoaddition product has formula 300:
wherein dashed lines indicate one or more optional bonds; RA is selected from the group consisting of H, alkyl, alkene, alkyne, aryl, heterocyclic, alkenyl halide, unsaturated enones, unsaturated ketones, unsaturated amides, unsaturated alcohols, unsaturated amines, unsaturated thiols, phosphonates, carboxylates, sulfonates, nitriles, thioethers, thioamides, thioketones, azides, sulfides, disulfides, ethers, epoxides, nitrates, nitrites, nitro compounds, nitroso compounds, imides, cyanates, isocyantes, thiocyanates, isothiocyanates, sulfoxides, sulfones, sulfites, phoshites, thial, phosphines, or aldheydes; RB is alkene, arene, or heteroarene; and each of R1, R2, and R3 is independently selected from alkyl, cycloalkyl, aryl, heterocyclic, alkoxy, aryloxy, amines, thiols, phosphonates, carboxylates, sulfonates, nitriles, thioethers, thioamides, thioketones, azides, sulfides, disulfides, ethers, epoxides, nitrates, nitrites, nitro compounds, nitroso compounds, imides, cyanates, isocyanates, thiocyanates, isothiocyanates, sulfoxides, sulfones, sulfites, phosphites, thial, phosphines, and aldehydes.
In certain embodiments, the photoaddition product has formula 300′:
wherein dashed lines indicate one or more optional bonds; RA is selected from the group consisting of H, alkyl, alkene, alkyne, aryl, heterocyclic, alkenyl halide, unsaturated enones, unsaturated ketones, unsaturated amides, unsaturated alcohols, unsaturated amines, unsaturated thiols, phosphonates, carboxylates, sulfonates, nitriles, thioethers, thioamides, thioketones, azides, sulfides, disulfides, ethers, epoxides, nitrates, nitrites, nitro compounds, nitroso compounds, imides, cyanates, isocyantes, thiocyanates, isothiocyanates, sulfoxides, sulfones, sulfites, phoshites, thial, phosphines, or aldheydes; RB is alkene, arene, or heteroarene; and each of R1, R2, and R3 is independently selected from alkyl, cycloalkyl, aryl, heterocyclic, alkoxy, aryloxy, amines, thiols, phosphonates, carboxylates, sulfonates, nitriles, thioethers, thioamides, thioketones, azides, sulfides, disulfides, ethers, epoxides, nitrates, nitrites, nitro compounds, nitroso compounds, imides, cyanates, isocyanates, thiocyanates, isothiocyanates, sulfoxides, sulfones, sulfites, phosphites, thial, phosphines, and aldehydes.
In certain embodiments, the photoaddition product is photoproduct 3a:
In certain embodiments, the photoaddition product is photoproduct 3b:
In certain embodiments, the photoaddition product is photoproduct 3c:
In certain embodiments, the photoaddition product is photoproduct 3d:
In certain embodiments, the photoaddition product is photoproduct 3e:
In certain embodiments, the photoaddition product is photoproduct 3f:
In certain embodiments, the photoaddition product is photoproduct 3g:
In certain embodiments, the photoaddition product is photoproduct 3h:
In certain embodiments, the light has a wavelength ranging from about 350 nm to about 420 nm. In certain embodiments, the light is visible light. In certain embodiments, the light is purple light. In certain embodiments, the light is provided by a purple LED or a UVA LED. In certain embodiments, the light is near-UV, UVA, UVB, or UVC light.
In certain embodiments, the solvent is selected from the group consisting of methanol, acetonitrile, ethylacetate, and toluene. In certain embodiments, the light is purple light and the solvent is selected from the group consisting of methanol, acetonitrile, ethylacetate, and toluene.
Further provided is a method for synthesizing a compound, the method comprising exposing an enaminone in a solvent to light to obtain a photoproduct. In certain embodiments, the photoproduct is the only product of the reaction with the enaminone and light.
In certain embodiments, the enaminone has formula IV:
wherein dashed lines represent a linker that can be an alkyl chain, a carbocyle, a heterocycle, or a combination of C—C and C-heteroatom bonds; and each of R1, R2, and R3 is, independently, H, alkyl, aryl, aryloxy, haloaryl, heterocycle, heteroatom, or a combination of carbocycle, chain, heterocycle, or heteroatom. In particular embodiments, R1 is an alkyl group. In particular embodiments, R1 is methyl. In particular embodiments, R2 is selected from the group consisting of methyl, phenyl, flourophenyl, naphthyl, and methoxy phenyl.
In certain embodiments, the enaminone has formula 400:
wherein dashed lines indicate one or more optional bonds; RA is selected from the group consisting of H, alkyl, alkene, alkyne, aryl, heterocyclic, alkenyl halide, unsaturated enones, unsaturated ketones, unsaturated amides, unsaturated alcohols, unsaturated amines, unsaturated thiols, phosphonates, carboxylates, sulfonates, nitriles, thioethers, thioamides, thioketones, azides, sulfides, disulfides, ethers, epoxides, nitrates, nitrites, nitro compounds, nitroso compounds, imides, cyanates, isocyantes, thiocyanates, isothiocyanates, sulfoxides, sulfones, sulfites, phoshites, thial, phosphines, or aldheydes; RB is alkene, arene, or heteroarene; and each of R1, R2, and R3 is independently selected from alkyl, cycloalkyl, aryl, heterocyclic, alkoxy, aryloxy, amines, thiols, phosphonates, carboxylates, sulfonates, nitriles, thioethers, thioamides, thioketones, azides, sulfides, disulfides, ethers, epoxides, nitrates, nitrites, nitro compounds, nitroso compounds, imides, cyanates, isocyanates, thiocyanates, isothiocyanates, sulfoxides, sulfones, sulfites, phosphites, thial, phosphines, and aldehydes.
In certain embodiments, the enaminone has formula 400′:
wherein dashed lines indicate one or more optional bonds; RA is selected from the group consisting of H, alkyl, alkene, alkyne, aryl, heterocyclic, alkenyl halide, unsaturated enones, unsaturated ketones, unsaturated amides, unsaturated alcohols, unsaturated amines, unsaturated thiols, phosphonates, carboxylates, sulfonates, nitriles, thioethers, thioamides, thioketones, azides, sulfides, disulfides, ethers, epoxides, nitrates, nitrites, nitro compounds, nitroso compounds, imides, cyanates, isocyantes, thiocyanates, isothiocyanates, sulfoxides, sulfones, sulfites, phoshites, thial, phosphines, or aldheydes; RB is alkene, arene, or heteroarene; and each of R1, R2, and R3 is independently selected from alkyl, cycloalkyl, aryl, heterocyclic, alkoxy, aryloxy, amines, thiols, phosphonates, carboxylates, sulfonates, nitriles, thioethers, thioamides, thioketones, azides, sulfides, disulfides, ethers, epoxides, nitrates, nitrites, nitro compounds, nitroso compounds, imides, cyanates, isocyanates, thiocyanates, isothiocyanates, sulfoxides, sulfones, sulfites, phosphites, thial, phosphines, and aldehydes.
In certain embodiments, the enaminone is enaminone 4a:
In certain embodiments, the enaminone is enaminone 4b:
In certain embodiments, the enaminone is enaminone 4c:
In certain embodiments, the enaminone is enaminone 4e:
In certain embodiments, the enaminone is enaminone 4d:
In certain embodiments, the enaminone is enaminone 4f:
In certain embodiments, the enaminone is enaminone 4g:
In certain embodiments, the enaminone is enaminone 4h:
In certain embodiments, the photoproduct is a bicyclic compound. In certain embodiments, the photoproduct is a dihydropyran. In certain embodiments, the photoproduct is bicylic compound that featuring a Marmycin core. In certain embodiments, the photoproduct is a marmycin analogue.
In certain embodiments, the photoproduct has formula III:
where the dashed lines represent a linker that can be an alkyl chain, a carbocycle or a heterocyclic moiety, or a combination of C—C or C-heteroatom bonds; and each of R1, R2, and R3 is, independently, H or a carbon-based chain, cyclic moiety, or heterocylic moiety. In particular embodiments, R1 is an alkyl group, and le is an alkyl, aryl, aryloxy, haloaryl, heterocycle, heteroatom, or a combination or carbocycle, chain, heterocycle, or heteroatom. In particular embodiments, R1 is methyl. In particular embodiments, R2 is selected from the group consisting of methyl, phenyl, and fluorophenyl, naphthyl, and methoxy phenyl, and R3 is H.
In certain embodiments, the photoproduct has formula 300:
wherein dashed lines indicate one or more optional bonds; RA is selected from the group consisting of H, alkyl, alkene, alkyne, aryl, heterocyclic, alkenyl halide, unsaturated enones, unsaturated ketones, unsaturated amides, unsaturated alcohols, unsaturated amines, unsaturated thiols, phosphonates, carboxylates, sulfonates, nitriles, thioethers, thioamides, thioketones, azides, sulfides, disulfides, ethers, epoxides, nitrates, nitrites, nitro compounds, nitroso compounds, imides, cyanates, isocyantes, thiocyanates, isothiocyanates, sulfoxides, sulfones, sulfites, phoshites, thial, phosphines, or aldheydes; RB is alkene, arene, or heteroarene; and each of R1, R2, and R3 is independently selected from alkyl, cycloalkyl, aryl, heterocyclic, alkoxy, aryloxy, amines, thiols, phosphonates, carboxylates, sulfonates, nitriles, thioethers, thioamides, thioketones, azides, sulfides, disulfides, ethers, epoxides, nitrates, nitrites, nitro compounds, nitroso compounds, imides, cyanates, isocyanates, thiocyanates, isothiocyanates, sulfoxides, sulfones, sulfites, phosphites, thial, phosphines, and aldehydes.
In certain embodiments, the photoproduct has formula 300′:
wherein dashed lines indicate one or more optional bonds; RA is selected from the group consisting of H, alkyl, alkene, alkyne, aryl, heterocyclic, alkenyl halide, unsaturated enones, unsaturated ketones, unsaturated amides, unsaturated alcohols, unsaturated amines, unsaturated thiols, phosphonates, carboxylates, sulfonates, nitriles, thioethers, thioamides, thioketones, azides, sulfides, disulfides, ethers, epoxides, nitrates, nitrites, nitro compounds, nitroso compounds, imides, cyanates, isocyantes, thiocyanates, isothiocyanates, sulfoxides, sulfones, sulfites, phoshites, thial, phosphines, or aldheydes; RB is alkene, arene, or heteroarene; and each of R1, R2, and R3 is independently selected from alkyl, cycloalkyl, aryl, heterocyclic, alkoxy, aryloxy, amines, thiols, phosphonates, carboxylates, sulfonates, nitriles, thioethers, thioamides, thioketones, azides, sulfides, disulfides, ethers, epoxides, nitrates, nitrites, nitro compounds, nitroso compounds, imides, cyanates, isocyanates, thiocyanates, isothiocyanates, sulfoxides, sulfones, sulfites, phosphites, thial, phosphines, and aldehydes.
In certain embodiments, the photoproduct is photoproduct 3a:
In certain embodiments, the photoproduct is photoproduct 3b:
In certain embodiments, the photoproduct is photoproduct 3c:
In certain embodiments, the photoproduct is photoproduct 3d:
In certain embodiments, the photoproduct is photoproduct 3e:
In certain embodiments, the photoproduct is photoproduct 3f:
In certain embodiments, the photoproduct is photoproduct 3g:
In certain embodiments, the photoproduct is photoproduct 3h:
In certain embodiments, the light has a wavelength ranging from about 350 nm to about 420 nm. In certain embodiments, the light is visible light. In certain embodiments, the light is purple light. In certain embodiments, the light is provided by a purple LED or a UVA LED. In certain embodiments, the light is near-UV light.
In certain embodiments, the solvent is selected from the group consisting of methanol, acetonitrile, ethylacetate, and toluene. In certain embodiments, the light is purple light and the solvent is selected from the group consisting of methanol, acetonitrile, ethylacetate, and toluene.
Further provided is a kit for preparing a marmycin analogue or core, the kit comprising a first container housing a 1,3-dicarbonyl compound or an enaminone; and a second container housing an alkene. In certain embodiments, the kit further comprises a light source.
The patent or application file may contain one or more drawings executed in color and/or one or more photographs. Copies of this patent or patent application publication with color drawing(s) and/or photograph(s) will be provided by the U.S. Patent and Trademark Office upon request and payment of the necessary fees.
Throughout this disclosure, various publications, patents, and published patent specifications are referenced by an identifying citation. The disclosures of these publications, patents, and published patent specifications are hereby incorporated by reference into the present disclosure in their entirety to more fully describe the state of the art to which this invention pertains.
Described herein is a previously unknown reactivity of carbonyl compounds, namely, excited state 1,3-dicarbonyl compounds, with alkenes to give dihydropyrans in a photochemical reaction referred to herein as interrupted photocycloaddition. Reactivity of 1,3-dicarbonyl compounds with alkenes leads to complex dihydropyrans. The reaction showcases how planar reactants can be transformed to bicyclic compounds with complex stereochemistry in one step with the help of light. The reaction gives one-step access to complex Marmycin core/analogues, which is an anti-cancer compound with multiple stereogenic centers, from planar starting materials. The reaction thus provides convenient access to the core of Marmycin and Marmycin analogues. The same products can be made by exposing enaminones to light. In either case, excellent isolated yields are possible with various light sources. A single product may be formed in one step, and no purification is needed.
The excited state chemistry of 1,3-dicarbonyl compounds, and in particular the de Mayo reaction, has an epochal impact for its versatility in the development of various products. The underlying reactivity traits of the de Mayo reaction is that of an excited α,β-enone that undergoes a [2+2]-photocycloaddition at the 3,4-position to form a cyclobutane followed by a retro-Aldol ring opening, resulting in a 1,5-dicarbonyl skeleton (
To alter the traditional reactivity of 1,3-dicarbonyl compounds takes an intricate understanding of the excited state dynamics involving deactivation pathways to control the highly reactive intermediate radicals that are formed during photochemical process. This necessities the manipulation of the reactive chromophores to channel their excited state energy. In other words, one has to limit the photoactivity along a known reaction trajectory and open a new pathway for excited state deactivation.
In accordance with the present disclosure, the photochemistry of 1,3-dicarbonyl compounds can be altered from its traditional reactivity (de Mayo reaction) by having activated alkenes as the reaction partner. The examples herein show the reactivity of 1,3-dicarbonyl compounds with alkenyl amines leading to bicyclo-dihydropyrans (
The examples herein begin with the evaluation of the photoactivity of commercially available 1-phenyl-1,3-butanedione la with amino-styrene 2a (
*The reaction mixture was purged with N2 for 30 min and was stirred at room temperature for 2 hours and then was subjected to irradiation as indicated in the table. % yield from 1H-NMR spectroscopy using triphenylmethane as internal standard.
To expand on the scope of the reaction (
The amino-styrene functionality was altered to gauge its influence on the observed reactivity. (
A change in the absorption profile (
Based on observation, the observed photoreaction between 1,3-dicarbonyl functionality and the alkenyl amine goes through an enaminone 4a. The enaminone 4a was independently synthesized, and its photochemical reactivity was evaluated under various conditions (
To generalize the reactivity of enaminone 4 leading to photoproduct 3, the reactivity of enaminones 4b-4h, which were independently synthesized from the corresponding diketones 1b-1f and 2a, 2b, respectively, was investigated. (
Alkyl substituted enaminones 4b (derived from 1b and 2a) and 4c (derived from 1c and 2a) were investigated. Irradiation of enaminone 4b in acetonitrile resulted in the corresponding photoproduct 3b in 40% isolated yield (
*The reaction mixture after purging with N2 was subjected to irradiation as indicated in the table. % yield was determined from 1H-NMR spectroscopy using triphenylmethane as internal standard.
The understand the observed reactivity, photophysical studies were performed on enaminones to understand their excited state properties. Enaminone 4a was utilized as a model system. (
On the basis of the photochemical and photophysical investigations, a mechanistic model for the observed reactivity is depicted in
Mechanistically, the reaction may occur from either singlet or triplet manifold via three distinct pathways (
Thus, as shown in the examples herein, the present disclosure reveals a photochemical reaction of 1,3-dicarbonyl compounds with alkenes such as alkenyl amines, leading to a complex bicyclic system. (
The methods described herein can be embodied in the form of a kit or kits. A non-limiting example of such a kit is a kit for preparing a marmycin analogue or core, the kit comprising a 1,3-dicarbonyl compound in a separate container from an alkene, where the containers may or may not be present in a combined configuration. Many other kits are possible, such as kits that further include a light source, or that include an enaminone and a light source in separate containers. The kits may further include instructions for using the components of the kit to practice the subject methods. The instructions for practicing the subject methods are generally recorded on a suitable recording medium. For example, the instructions may be present in the kits as a package insert or in the labeling of the container of the kit or components thereof. In other embodiments, the instructions are present as an electronic storage data file present on a suitable computer readable storage medium, such as a flash drive or CD-ROM. In other embodiments, the actual instructions are not present in the kit, but means for obtaining the instructions from a remote source, such as via the internet, are provided. An example of this embodiment is a kit that includes a web address where the instructions can be viewed and/or from which the instructions can be downloaded. As with the instructions, this means for obtaining the instructions is recorded on a suitable substrate.
The present examples describe the origin and scope of interrupted photocycloaddition with photophysical and mechanistic investigations. A previously unknown photoreactivity of 1,3-dicarbonyl compounds was observed with amino-alkenes leading to dihydropyrans. This photochemical reactivity changes the established paradigm related to the de Mayo reaction between 1,3-dicarbonyl compounds and alkenes. This reaction allows convenient access to the Marmycin core in a single step from commercially available reactants.
All commercially obtained reagents/solvents were used as received; chemicals were purchased from Alfa Aesar®, Sigma-Aldrich®, Acros organics®, TCI America®, and Oakwood® Products, and were used as received without further purification. Spectrophotometric grade solvents (e.g. acetonitrile, ethanol) were purchased from Sigma-Aldrich® and used without further purification for emission measurements. Purple LED (˜390 nm) irradiation was conducted with Onforu 50W LED flood lights, 5500 lm purchased from Amazon. Rayonet reactor (Southern New England Ultraviolet CO.—RPR-100/RPR-200) was employed for ˜350 nm and ˜420 nm irradiations. Unless stated otherwise, reactions were conducted in oven-dried glassware under nitrogen atmosphere. 1H-NMR and 13C-NMR spectra were recorded on Bruker 500 MHz (125 MHz for 13C) spectrometers. Data from the 1H-NMR spectroscopy are reported as chemical shift (δ ppm) with the corresponding integration values. Coupling constants (J) are reported in hertz (Hz). Standard abbreviations indicating multiplicity were used as follows: s (singlet), b (broad), d (doublet), t (triplet), q (quartet), m (multiplet), and virt (virtual). Data for 13C NMR spectra are reported in terms of chemical shift (δ ppm). High-resolution mass spectrometry (HRMS) was performed either using a Waters Synapt high-definition mass spectrometer with a nano-electrospray ionization (ESI) source (Waters, Milford, Mass.) with Lucein ENKEPHALIN (molecular mass 556.2771) as internal standard, or on a Waters ToF instrument, model SYNATP G2-Si using electron spray ionization (ESI) on positive mode. GC/MS data was recorded in GC-2010 Gas Chromatograph. Concentrations of 3 mg/10 mL of sample in chloroform was employed for analysis. When necessary, the compounds were purified by chromatography using a Combiflash SI-3 system equipped with dual wavelength UV-Vis absorbance detector (Teledyne ISCO) using hexanes:ethyl acetate solvent mixture as the mobile phase and Redisep® cartridge filled with silica (Teledyne ISCO) as stationary phase. In some cases, compounds were purified by column chromatography on silica gel (Sorban Technologies®, silica gel standard grade: porosity 60 Å, particle size: 230×400 mesh, surface area: 500-600 m2/g, bulk density: 0.4 g/mL, pH range: 6.5-7.5). Unless indicated, the Retardation Factor (Rf) values were recorded using 5-50% hexanes:ethyl acetate as mobile phase and on Sorbent Technologies®, silica gel TLC plates (200 mm thickness w/UV254). HPLC analyses were performed on WatersR HPLC equipped with 2525 pump or on DionexR Ultimate 3000 HPLC. WatersR 2767 sample manager was used for automated sample injection on WatersR HPLC or Ultimate 3000 sample injector was used for injection on DionexR HPLC. All HPLC injections on WatersR HPLC were monitored using a WatersR 2487 dual wavelength absorbance detector at 254 and 270 nm or on DionexR. HPLC were monitored using a diode array detector (DAD3000125). Analytical and semi-preparative injections were performed on chiral stationary phase using various columns as indicated below.
Spectrophotometric solvents (Sigma-Aldrich®) were used whenever necessary unless or otherwise mentioned. UV quality fluorimeter cells (with range until 190 nm) were purchased from Luzchem®. Absorbance measurements were performed using a Cary 300 UV-Vis spectrophotometer. Emission experiments were done FLS1000 spectrometer from Edinburgh Instruments. Steady-state fluorescence measurements at room temperature were performed on a Fluorolog-3 fluorometer (HORIBA Jobin Yvon). Fluorescence quantum yields were estimated using 9,10-diphenylanthracene as standard. Time-resolted phosphorescence measurements were recorded on a Fluorolog-3P fluorometer (HORIBA Jobin Yvon). Ethanol samples solutions in 3-mm quartz tubes (inner diameter) were frozen in a quartz liquid nitrogen Dewar (77 K) and excited with a pulsed xenon lamp. Phosphorescence lifetimes at 77 K for BTD and CN-BTD were measured by multichannel scaling on an OB920 spectrometer (Edinburgh Analytical Instruments) in conjunction with a pulsed xenon lamp.
Single crystal X-ray diffraction data of the compounds 3a and 3e were collected on a a Bruker AXS D8 Quest Eco CMOS diffractometer PHOTON II detector at T=100 K. Cu Kα radiation=1.54178Å was used. All structures were processed with Apex 2 v2014.1-0 software package SAINT V8.30C (Bruker, 2013) for cell refinement and SAINT V8.30C (Bruker, 2013) for data reduction, and Olex 2 v 1.3.0 was used to solve the structure. Single crystal X-ray diffraction data of the compounds 4a and 4c were collected on a Bruker Apex Duo diffractometer with a Apex 2 CCD area detector at T=105 K. Cu radiation was used. All structures were processed with Apex 2 v2010.9-1 software package (SAINT v. 7.68A, XSHELL v. 6.3.1,OLEX). XT structure solution program based on intrinsic phasing was used to solve the structures after multi-scan absorption corrections and refined with the XL refinement package using least squares minimization. Direct method was used to solve the structures after multi-scan absorption corrections.
Cyclic voltammetry was performed either on a BASi EC Epsilon potentiostat or PINE instrument with Epsilon software. A cell consisting of three electrodes, i.e., Pt wire counter electrode, glassy carbon working electrode, and Ag/AgNO3 (0.01 M AgNO3, 0.1 M n-Bu4N+PF6 in CH3CN) as reference electrode was employed for measurements.
Chemical Structures of Photoproducts and Precursors used in the Photoreactions
The synthesis of styrene amine 2a is shown in the scheme depicted in
Amino-styrene amine 2a was synthesized as follows. A mixture of 2-(2-aminophenyl)ethanol (36.4 mmol, 1 equiv.) and KOH (36.4 mmol, 1 equiv.) was refluxed at a temperature of 180° C. for 4 hours. The reaction completion was monitored by TLC. After completion of the reaction, the reaction mixture was cooled to around 50° C. Cooling to room temperature was avoided as further dissolution of solidified crude materials becomes difficult during workup. To the crude reaction mixture DI water (20 mL) was added to dissolve excess KOH, followed by ethyl acetate (60 mL). The organic layer was separated. Aqueous layer was extracted with ethyl acetate (10 mL×3). Combined organic layer was washed with 10 mL of brine solution, dried over anhydrous sodium sulfate, and filtered, and solvent was removed under reduced pressure. The crude product was purified by Combiflash using ethyl acetate/hexanes mixture as mobile phase. Rf=0.3 (90% hexanes:10% ethyl acetate) Yield=40%. 1H NMR (500 MHz, CDCl3, δ ppm): 11.49 (s, 1H), 7.93-7.84 (m, 2H), 7.49-7.36 (m, 3H), 5.93 (ddt, J=17.2, 10.2, 5.0 Hz, 1H), 5.74 (s, 1H), 5.34-5.28 (m, 1H), 5.24 (dq, J=10.3, 1.5 Hz, 1H), 3.98 (ddt, J=6.6, 5.0, 1.8 Hz, 2H), 2.09 (s, 3H). 13C NMR (125 MHz, CDCl3, δ ppm): 187.95, 164.99, 140.35, 133.74, 130.49, 128.17, 126.92, 116.54, 92.41, 45.42, 19.21. The NMR spectra of the styrene amine 2a is shown in
The synthesis of amino-styrene 2b is shown in the scheme depicted in
Isopropenylaniline 2b was synthesized as follows. A mixture of PPh3MeBr (1.5 equiv) in dry THF (˜10mL) was cooled to 0° C., followed by the addition of KOtBu (1.5 equiv). The resulting mixture was stirred for 30 minutes at room temperature and then re-cooled to 0° C. and 2-aminoacetophenone was added (1 equiv). The mixture was allowed to warm to room temperature and monitored by TLC for the completion of the reaction. A saturated solution of NaHCO3 was added to quench the reaction, the mixture was diluted and extracted with ethylacetate (3×10 mL). The combined organic phases were washed with brine, dried over sodium sulfate, filtered and concentrated under reduced pressure. The crude product was purified by column chromatography using ethyl acetate/hexanes mixture as mobile phase.
Rf=0.3 (90% hexanes:10% ethyl acetate). Yield=50%. 1H-NMR (500 MHz, CDCl3, 6 ppm): 7.06 (ddd, J=15.0, 7.3, 1.6 Hz, 2H), 6.78-6.68 (m, 2H), 5.30 (dq, J=3.0, 1.6 Hz, 1H), 5.07 (dq, J=1.9, 0.9 Hz, 1H), 3.90 (s, 2H), 2.11-2.06 (m, 3H). 13C-NMR (126 MHz, CDCl3, δ ppm): 143.6, 142.8, 129.5, 128.4, 128.0, 118.4, 115.7, 115.5, 24.0.
The synthesis of 1,3-diketones 1c-1e is depicted in
1,3-diketones 1c-1f were synthesized by the following procedure. Solution of aryl ketone 8 (6.6 mmol, 1 equiv.) in ethyl acetate (5 mL) was added to the suspension of sodium hydride (26.6 mmol, 4 equiv.) in ethyl acetate (5 mL) at 0° C. and stirred at room temperature for 12 h. Completion of the reaction was monitored by TLC, after which saturated solution of ammonium chloride (20 mL) was added followed by the acidification with dil. HCl (20 mL of 10% aqueous HCl solution). Organic layer was separated. Aqueous layer was extracted with ethyl acetate (3×10 mL). Combined organic layer was washed with 10 mL of brine solution and dried with anhydrous sodium sulfate, and concentrated under reduced pressure. The crude product was purified by Combiflash using ethyl acetate/hexanes mixture as mobile phase.
General Procedure for Synthesis of Enaminones 4a-4h
Enaminones 4a-4h were synthesized by following the reported procedure. A mixture of amino-styrene 2a or 2b (2.1 mmol, 1 equiv.), 1,3 butadione derivative (1 equiv.), and formic acid (10 μL, 0.01 equiv.) was refluxed at 85° C. for 4 h in ethanol (15 mL). Completion of the reaction was monitored by TLC and after completion of the reaction, it was cooled to room temperature. To the crude reaction mixture DI water (20 mL) and ethyl acetate (60 mL) was added. Organic layer was separated. Aqueous layer was extracted with ethyl acetate (3×10 mL). Combined organic layer was washed with brine solution and dried with anhydrous sodium sulfate and concentrated under reduced pressure. The crude product was purified by Combiflash using ethyl acetate/hexanes mixture as mobile phase.
A mixture of amino-styrene 2a (2.5 mmol, 1 equiv.), 1 phenyl-1,3 butadione (3.5 mmol, 1.4 equiv.), and formic acid (10 μL, 0.01 equiv.) was subjected to microwave irradiation for 30 seconds to give the E/Z isomer mixture of the enaminone 4a, which was confirmed by 1H NMR spectroscopy. Heating this isomer mixture at 85° C. for 10 minutes resulted in the formation of the Z-isomer as the major product. The reaction was monitored by crude 1H-NMR spectroscopy. (
Rf=0.5 (70% hexanes:30% ethyl acetate) Yield=50%. 1H NMR (500 MHz, CDCl3, δ ppm, major Z-4a with trace of E-4a): 12.88 (s, 1H), 8.02-7.85 (m, 2H), 7.68-7.57 (m, 2H), 7.45 (tddd, J=8.8, 6.1, 2.8, 1.6 Hz, 3H), 7.32-7.26 (m, 2H) 7.19-7.13 (m, 1H), 6.92 (dd, J=17.5, 11.1 Hz, 1H) 5.93 (s, 1H), 5.78 (dd, J=17.5, 1.1 Hz, 1H), 5.36 (dd, J=11.1, 1.1 Hz, 1H), 1.96 (s, 3H). 13C NMR (125 MHz, 6 ppm major Z-4a with trace of E-4a): 189.0, 163.7, 140.1, 136.2, 134.6, 132.4, 132.2, 131.0, 128.8, 128.4, 127.5, 127.3, 127.2, 127.1, 126.3, 116.9, 96.9, 93.8, 26.0, 20.4. HRMS-ESI (m/z) ([M+H]+): Calculated: 264.1388; Observed: 264.1386; |Δm|: 0.7 ppm.
Rf=0.5 (90% hexanes:10% ethyl acetate) Yield=92%. 1H NMR (500 MHz, CDCl3, δ ppm, major Z-4b with trace of E-4b): 12.29 (s, 1H), 7.62-7.55 (m, 1H), 7.28-7.26 (m, 1H), 7.25-7.22 (m, 1H), 7.12-7.07 (m, 1H), 6.86 (dd, J=17.5, 11.0 Hz, 1H), 5.74 (dd, J=17.5, 1.2 Hz, 1H), 5.34 (dd, J=11.1, 1.1 Hz, 1H), 5.21 (s, 1H), 2.12 (s, 3H), 1.81 (s, 3H). 13C-NMR (126 MHz, CDCl3, δ ppm, major Z-4a with trace of E-4a): 196.4, 161.7, 136.2, 134.5, 132.1, 128.3, 127.4, 127.1, 126.2, 116.7, 97.1, 29.2, 19.7. HRMS-ESI (m/z)([M+H]+): Calculated: 202.1231; Observed: 202.1237; |Δm|=2.9 ppm.
Rf=0.5 (90% hexanes:10% ethyl acetate) Yield=68%. 1H-NMR (500 MHz, CDCl3, δ ppm, major Z-4c with trace of E-4c): 12.83 (s, 1H), 8.01-7.89 (m, 2H), 7.66-7.58 (m, 1H), 7.33-7.26 (m, 2H), 7.19-7.14 (m, 1H), 7.14-7.05 (m, 2H), 6.91 (dd, J=17.5, 11.0 Hz, 1H), 5.87 (s, 1H), 5.78 (dd, J=17.5, 1.1 Hz, 1H), 5.37 (dd, J=11.1, 1.1 Hz, 1H), 1.95 (s, 3H). 13C-NMR (126 MHz, CDCl3, δ ppm, major Z-4c with trace of E-4c): 187.5, 165.7 and 163.7 (JC-F: 252 Hz), 163.9, 136.32 and 136.29 (JC-F: 3.8 Hz), 136.1, 134.6, 132.1, 129.52 and 129.45 (JC-F: 8.8 Hz), 128.4, 127.5, 127.4, 126.3, 117.0, 115.41 and 115.24 (JC-F: 21.4 Hz), 93.4, 20.4. 19F-NMR (376 MHz, CDCl3, δ ppm): Peak centered around −106.9 (minor) and −109.9 (major). HRMS-ESI (m/z) ([M+H]+): Calculated: 282.1294; Observed: 282.1299; |Δm|=1.7 ppm
Rf=0.5 (90% hexanes:10% ethyl acetate) Yield=92%. 1H-NMR (500 MHz, CDCl3, δ ppm, major Z-4e with trace of E-4e): 12.83 (s, 1H), 7.96-7.89 (m, 2H), 7.64-7.57 (m, 1H), 7.31-7.22 (m, 3H, with overlapping solvent peaks), 7.18-7.11 (m, 1H), 6.99-6.85 (m, 3H), 5.77 (dd, J=17.5, 1.1 Hz, 1H), 5.36 (dd, J=11.1, 1.1 Hz, 1H), 3.87 (s, 3H), 1.95 (s, 3H). 13C-NMR (126 MHz, CDCl3, δ ppm major Z-4e with trace of E-4e): 188.0, 162.8, 162.0, 136.3, 134.5, 132.7, 132.2, 129.1, 129.0, 128.2, 127.4, 127.0, 126.2, 116.6, 113.9, 113.5, 95.8 (E-isomer), 93.2 (Z-isomer), 55.4, 25.3 (E-isomer), 20.2 (Z-isomer). HRMS-ESI (m/z) ([M+H]+): Calculated: 294.1494; Observed: 294.1499; |Δm|=1.6 ppm.
Rf=0.5 (90% hexanes:10% ethyl acetate) Yield=91%. 1H NMR (500 MHz, CDCl3, δ ppm): 12.90 (s, 1H), 8.57-8.49 (m,1H), 7.89 (ddd, J=9.5, 7.9, 1.3 Hz, 2H), 7.73 (dd, J=7.1, 1.3 Hz,1H), 7.68-7.62 (m, 1H), 7.57-7.47 (m, 3H), 7.35-7.29 (m, 2H), 7.25-7.20 (m, 1H), 7.02 (dd, J=17.5, 11.0 Hz, 1H), 5.83 (dd, J=17.5, 1.1 Hz, 1H), 5.72 (s, 1H), 5.43 (dd, J=11.0, 1.1 Hz, 1H), 1.96 (s, 3H). 13C-NMR (126 MHz, CDCl3, δ ppm): 193.2, 163.5, 140.1, 136.1, 134.5, 133.9, 132.2, 130.4,130.0, 128.4, 128.3, 127.5, 127.3, 126.6, 126.4, 126.3, 126.0, 125.6, 125.0, 117.0, 98.6, 20.2. HRMS-ESI (m/z) ([M+H]+): Calculated: 314.1544; Observed: 314.1543; |Δm|=0.3 ppm.
Rf=0.5 (90% hexanes:10% ethyl acetate) Yield=91%. 1H-NMR (500 MHz, CDCl3, δ ppm, Z-4f with trace of E-4f): 12.8 (s, 1H), 7.6-7.6 (m, 1H), 7.5-7.4 (m, 2H), 7.3-7.2 (m, 2H), 7.2-7.1 (m, 1H), 7.0-6.8 (m, 2H), 5.84 (s, 1H), 5.77 (dd, J=17.5, 1.1 Hz, 1H), 5.3 (dd, J=11.0, 1.1 Hz, 1H), 4.3 (ttd, J=7.1, 3.4, 1.6 Hz, 4H), 1.9 (s, 3H). 13C-NMR (126 MHz, CDCl3, δ ppm, major Z-4f with trace of E-4f): 187.9, 163.1, 146.4, 143.4, 136.5, 134.6, 133.9, 132.3, 128.4, 127.6, 127.2, 126.3, 121.0, 117.1, 116.8, 116.7, 93.4, 64.8, 64.4, 20.4. HRMS-ESI (m/z) ([M+H]+): Calculated: 322.1443; Observed: 322.1462; |Δm|=5.9 ppm.
Rf=0.5 (90% hexanes:10% ethyl acetate) Yield=91%. 1H-NMR (500 MHz, CDCl3, δ ppm, Z-4e with trace of E-4e): 12.83 (s, 1H), 7.96-7.90 (m, 2H), 7.47-7.39 (m, 3H), 7.33-7.20 (m, 3H), 7.16 (dd, J=7.7, 1.5 Hz, 1H), 5.89 (s, 1H), 5.26 (t, J=1.7 Hz, 1H), 5.08-5.04 (m, 1H), 2.05 (t, J=1.2 Hz, 3H), 2.01 (s, 3H). 13C-NMR (126 MHz, CDCl3, δ ppm, major Z-4g with trace of E-4g): 193.9, 188.8, 183.5, 163.0, 143.6, 140.8, 140.3, 135.7, 132.4, 130.9, 129.5, 128.8, 128.4, 127.8, 127.3, 127.2, 126.8, 117.2, 96.9 (minor isomer), 93.9 (major isomer), 26.0 (minor isomer), 23.4 (major isomer), 20.3. HRMS-ESI (m/z) ([M +H]+): Calculated: 278.1545; Observed: 278.1533; |Δm|=4.3 ppm.
Rf=0.5 (90% hexanes:10% ethyl acetate) Yield=91%. 1H-NMR (500 MHz, CDCl3, δ ppm, major Z-4h with trace of E-4h): 12.78 (s, 1H), 7.96-7.86 (m, 2H), 7.32-7.21 (m, 3H, with overlapping solvent peaks), 7.18-7.04 (m, 3H), 5.83 (s, 1H), 5.25 (m, 1H), 5.05 (dq, J=1.8, 0.9 Hz, 1H), 2.04 (dd, J=1.5, 0.9 Hz, 3H), 2.00 (s, 3H). 13C-NMR (126 MHz, CDCl3, δ ppm, major Z-4h with trace of E-4h): 187.3, 165.7 and 163.7 (JC-F=252 Hz), 163.2, 143.53, 140.76, 136.49 and 136.47 (JC-F=2.5 Hz), 135.62, 129.53 and 129.48 (JC-F=6.3 Hz), 129.46, 127.82, 127.14, 126.93, 117.21, 115.34 and 115.17 (JC-F=21.4 Hz), 93.47, 23.42, 20.32. 19F-NMR (376 MHz, CDCl3, δ ppm): Peaks centered around −106.88 and −110.08. HRMS-ESI (m/z) ([M +H]+): Calculated: 296.1451; Observed: 296.1467; |Δm|=5.4 ppm.
Enaminone 6a, 6b was synthesized as follows. To a solution of 4 (0.76 mmol, 1 equiv.) in DCM (10 mL), triethylamine (0.76 mmol, 1 equiv.), 4-(dimethylamino)pyridine (0.07 mmol, 0.09 equiv.), and di-tert-butyl dicarbonate (0.91 mmol, 1.2 equiv.) were added at 0° C. After stirring at ambient temperature for 30 minutes, the crude reaction mixture was diluted by the adding saturated aqueous NH4Cl solution (10 mL). Organic layer was separated. The compounds from the aqueous layer was extracted with ethyl acetate (3×10 mL). Combined organic layer was washed with 10 mL of brine solution and dried over anhydrous sodium sulfate and concentrated under reduced pressure. The crude product was purified by chromatography (Combiflash) using ethyl acetate/hexanes mixture as mobile phase.
Rf=0.3 (70% hexanes:30% ethyl acetate) Yield=20%. 1H-NMR (500 MHz, CDCl3, δ ppm, mixture of E/Z isomers): 7.72-7.69 (m, 2H), 7.66-7.63 (m, 1H), 7.47-7.43 (m, 1H), 7.38-7.32 (m, 4H), 7.15-7.11 (m, 1H), 6.77-6.69 (m, 1H), 6.51 (q, J=0.8 Hz, 1H), 5.79 (dd, J=17.5, 1.1 Hz, 1H), 5.36 (dd, J=11.0, 1.1 Hz, 1H), 2.57 (d, J=0.8 Hz, 3H), 1.38 (s, 9H). 13C-NMR (126 MHz, CDCl3, δ ppm, mixture of E/Z isomers): 191.0, 157.1, 152.9, 140.2, 139.4, 135.8, 132.1, 131.9, 129.0, 128.9, 128.8, 128.6, 128.5, 128.4, 128.4, 128.0, 126.2, 117.0, 112.8, 82.5, 53.6, 28.1, 19.9.
Rf=0.5 (80% hexanes:20% ethyl acetate) Yield=37%. 1H-NMR (500 MHz, CDCl3, 6 ppm): 7.63-7.59 (m, 1H), 7.35-7.27 (m, 2H), 7.06-7.02 (m, 1H), 6.65 (dd, J=17.5, 11.1 Hz, 1H), 5.86 (s, 1H), 5.76 (dd, J=17.5, 1.1 Hz, 1H), 5.34 (dd, J=11.1, 1.1 Hz, 1H), 2.44 (d, T=0.8 Hz, 3H), 2.07 (s, 3H), 1.35 (s, 9H). 13C-NMR (126 MHz, CDCl3, δ ppm): 198.0, 155.3, 152.8, 139.2, 135.8, 131.9, 128.8, 128.3, 126.1, 116.8, 115.5, 82.3, 32.5, 28.0, 19.3.
General Procedure for the Photoreaction of Enaminones 4a-4h at 350 nm and 390 nm (Purple LED) to Form the Corresponding Photoproduct 3a-3h
UV-Vis absorption spectra of solution was taken to determine the optical density (OD) at the irradiation wavelength. The concentration of reaction mixture was adjusted to have an optical density (OD) of ˜0.2 at the irradiation wavelength to avoid any inner filter effect.
Enaminone 4a-4h was dissolved in acetonitrile. Enaminone solution (0.15 mM-0.02 mM depending n the enaminone at ˜0.2 OD) was taken in a Pyrex test tube and was purged with nitrogen for ˜15-30 min. It was then irradiated in a Rayonet reactor at ˜350 nm or with purple LED. Progress of the reaction was monitored at a regular interval of time by recording the crude 1H-NMR spectra of the reaction mixture. After the completion of the reaction, the solvent was evaporated and concentrated under reduced pressure. The crude product was purified by chromatography (Combiflash) using ethyl acetate/hexanes mixture as mobile phase for ˜350 nm irradiation and the isolated yields were recorded. For purple LED irradiations, after the completion of the reaction, a known amount of internal standard (triphenyl methane) was added. Solvent was removed under the reduced pressure. Product yield was determined by 1H-NMR spectroscopy using triphenylmethane internal standard. For irradiation times and yields, refer to
Solvent optimization for the photoreaction of 4a for the formation of photoproduct 3a using 1H-NMR studies
Table 3—Optical density at the irradiation wavelength for carrying out the photoreaction of enaminones 4a-4c, 4e in methanol
Enaminone 4a (0.015 mM, in MeOH) was degassed with nitrogen purging (˜15 minutes) and was stirred at room temperature for 12 h. The reaction mixture was monitored by 1H-NMR spectroscopy at various time intervals. Analysis of the crude reaction mixture showed only the starting material and dihydropyran product was not observed under thermal conditions.
General Procedure for the One Pot Reaction of 1,3-Diketones with Amino-Styrene 2 under Light Irradiation to Form Photo Products 3a-3h
Amino-styrene 2 (0.34 mmol, 1 equiv.), corresponding diketone (1.1 equiv.), and formic acid (0.01 equiv.) were dissolved in methanol in a round bottom flask. With the previous knowledge of concentration of enaminone required for the OD of 0.2 at the irradiation wavelength, the corresponding concentration of amino-styrene and 1,3-diketone was determined. At this concentration, the mixture of styrene amine 2a (1 equiv.) and 1,3-diketone (1.1 equiv) in methanol was stirred in Pyrex test tube at room temperature for 2 h for the formation of enaminone. The completion of reaction for the enaminone formation was confirmed from crude 1H-NMR spectroscopy. The reaction mixture was dissolved in 120 mL of methanol and was transferred to 8 Pyrex test tubes and degassed with nitrogen for 15 min. It was followed by the irradiation in a Rayonet reactor with a light source of —350 nm. Progress of the reaction was monitored by crude 1H-NMR spectroscopy of the reaction mixture. After the completion of the reaction, solvent was removed under the reduced pressure. The crude product was purified by chromatography (Combiflash) using ethyl acetate/hexanes mixture as mobile phase. For irradiation times and yields, refer to
As noted above,
The reaction yield for this substrate was low (˜2%). This prevented the characterization of this product by NMR spectroscopy. Crude 1H-NMR spectroscopy (with solvent peaks) is provided in
Characterization of Photoproduct 3a with x-ray Crystallography and COSY Spectra
The photoproduct was injected in the HPLC chiral RR column, and at 90:10 isopropyl alcohol:hexane ratio. Good separation between the isomers of the photoproduct was achieved. Stationary phase: CHIRALPAK-RR column. Mobile phase (Hexane:IPA): 90:10. Detection wavelength (1): 272 nm. Flow: 1 ml/min.
The excitation spectra of the photoproduct 3a was recorded at emission maxima of 420 nm. Since the absorption and excitation spectra did not match, the presence of secondary photophysical processes after the initial excitation can be confirmed.
Energy transfer catalyzed photoreaction of 4 with thioxanthone as the triplet sensitizer
The enaminone 4 (1 equiv.) was taken in a Pyrex test tube, with thioxanthone (TX=5 mol %) in MeOH (15 mL). The reaction mixture was degassed with nitrogen bubbling (15 min) and was irradiated at ˜420 nm in a Rayonet reactor. 1H-NMR spectrum (
The N-Boc derivative 6a (in MeOH, 0.014 mmol) or 6b (in MeCN, 0.016 mmol) was degassed with nitrogen purging (˜15 minutes) and was irradiated at ˜350 nm. The reaction progress was monitored by 1H-NMR spectroscopy at various time intervals. Analysis of the crude reaction mixture shows that the N-Boc derivative 6b did not give the desired dihydropyran product. An unidentified side product was observed for 6a. The crude 1H-NMR spectra of the irradiated mixture of 6b at different time intervals is given in
The table in
A mixture of 2-ethylaniline 9 (2.4 mmol, 1 equiv.), 1-phenyl butanedione (2.4 mmol, 1 equiv.), and formic acid (0.01 equiv.) was stirred at 85° C. in MeOH (10 mL) for 4 hours. The reaction was monitored by TLC. After the completion of the reaction, it was cooled to room temperature and was concentrated under reduced pressure. To the crude reaction mixture DI water (10 mL) and ethyl acetate (20 mL) were added. The compounds were extracted to the organic layer. This organic layer was separated and dried over anhydrous sodium sulphate, and concentrated under reduced pressure. The crude product was purified by chromatography (Combiflash) using ethyl acetate/hexanes mixture as mobile phase to obtain product 10a (Rf=0.5, 90% hexanes:10% ethyl acetate). Yield=80%.
A mixture of enaminone 10a (0.802 mmol, 1 equiv.), di-tert-butyl dicarbonate (0.882 mmol, 1.1 equiv.), triethylamine (1.4 mmol, 1.7 equiv.), 4-(dimethylamino)pyridine (0.05 mmo1,0.06 equiv.) in dry DCM was stirred at room temperature for 30 min. To the crude reaction mixture DI water (20 mL) and ethyl acetate (20 mL) were added. Organic layer was separated and the compounds from the aqueous layer were extracted with ethyl acetate (3×10 mL). Combined organic layer was dried with anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The crude product was purified by chromatography (Combiflash) using ethyl acetate/hexanes mixture as mobile phase to obtain product 5a (Rf=0.3, 10% Hexanes:Ethylacetate). Yield =20%.
Rf=0.5 (90% hexanes:10% ethyl acetate). Yield=80%. 1H-NMR (500 MHz, C6D6, δ ppm) 13.59 (s, 1H), 8.20-8.12 (m, 2H), 7.23-7.17 (m, 3H), 7.00-6.87 (m, 3H), 6.78-6.70 (m, 1H), 5.89 (s, 1H), 2.55 (q, J=7.6 Hz, 2H), 1.61 (s, 3H), 1.09 (t, J=7.5 Hz, 3H). 13C-NMR (126 MHz, CDCl3, δ ppm) 188.7, 163.5, 140.2, 139.9, 136.8, 130.9, 129.3, 128.3, 127.2, 127.1, 126.9, 126.5, 93.7, 24.9, 20.3, 14.7.
Rf=0.5 (80% hexanes:20% ethyl acetate). Yield=20%. 1H-NMR (500 MHz, CDCl3, 6 ppm) 8.12-7.89 (m, 2H), 7.57-7.50 (m, 1H), 7.50-7.41 (m, 2H), 7.33-7.23 (m, 3H), 7.18 (td, J=7.4, 1.8 Hz, 1H), 6.59 (d, J=1.2 Hz, 1H), 2.65 (dq, J=14.8, 7.4 Hz, 2H), 1.82 (d, J=1.1 Hz, 3H), 1.29 (s, 9H), 1.25 (t, J=7.6 Hz, 3H). 13C-NMR (126 MHz, CDCl3, δ ppm) 188.8, 152.9, 148.8, 142.3, 138.9, 138.9, 132.4, 128.7, 128.6, 128.5, 128.3, 128.0, 126.5, 114.6, 81.2, 28.1, 23.4, 23.3, 14.2.
Certain embodiments of the compositions and methods disclosed herein are defined in the above examples. It should be understood that these examples, while indicating particular embodiments of the invention, are given by way of illustration only. From the above discussion and these examples, one skilled in the art can ascertain the essential characteristics of this disclosure, and without departing from the spirit and scope thereof, can make various changes and modifications to adapt the compositions and methods described herein to various usages and conditions. Various changes may be made and equivalents may be substituted for elements thereof without departing from the essential scope of the disclosure. In addition, many modifications may be made to adapt a particular situation or material to the teachings of the disclosure without departing from the essential scope thereof.
This application claims priority to U.S. Provisional Application No. 63/019,484 filed under 35 U.S.C. § 111(b) on May 4, 2020, the disclosure of which is incorporated herein by reference in its entirety for all purposes.
This invention was made with government support under Grant Numbers CHE1811795 and CHE-1955524 awarded by the National Science Foundation. The government has certain rights in this invention.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2021/030573 | 5/4/2021 | WO |
Number | Date | Country | |
---|---|---|---|
63019484 | May 2020 | US |